These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8313374)

  • 1. Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype.
    Frebourg T; Sadelain M; Ng YS; Kassel J; Friend SH
    Cancer Res; 1994 Feb; 54(4):878-81. PubMed ID: 8313374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.
    Srivastava S; Wang S; Tong YA; Pirollo K; Chang EH
    Oncogene; 1993 Sep; 8(9):2449-56. PubMed ID: 8361758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
    Runnebaum IB; Yee JK; Kieback DG; Sukumar S; Friedmann T
    Anticancer Res; 1994; 14(3A):1137-44. PubMed ID: 8074464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactive p53 mutants may enhance the transcriptional activity of wild-type p53.
    Zhang W; Shay JW; Deisseroth A
    Cancer Res; 1993 Oct; 53(20):4772-5. PubMed ID: 8402659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences.
    Chen JY; Funk WD; Wright WE; Shay JW; Minna JD
    Oncogene; 1993 Aug; 8(8):2159-66. PubMed ID: 8336941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
    Willis A; Jung EJ; Wakefield T; Chen X
    Oncogene; 2004 Mar; 23(13):2330-8. PubMed ID: 14743206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant negative effect of a germ-line mutant p53: a step fostering tumorigenesis.
    Srivastava S; Wang S; Tong YA; Hao ZM; Chang EH
    Cancer Res; 1993 Oct; 53(19):4452-5. PubMed ID: 8402611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles.
    Rand A; Glenn KS; Alvares CP; White MB; Thibodeau SM; Karnes WE
    Cancer Lett; 1996 Jan; 98(2):183-91. PubMed ID: 8556707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro analysis of the dominant negative effect of p53 mutants.
    Chène P
    J Mol Biol; 1998 Aug; 281(2):205-9. PubMed ID: 9698540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of transcription reporters with novel p53 binding sites to target tumour cells expressing endogenous or virally transduced p53 mutants with altered sequence-specificity.
    Gagnebin J; Kovar H; Kajava AV; Estreicher A; Jug G; Monnier P; Iggo R
    Oncogene; 1998 Feb; 16(5):685-90. PubMed ID: 9482117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 transdominance but no gain of function in mouse brain tumor model.
    Hegi ME; Klein MA; Rüedi D; Chène P; Hamou MF; Aguzzi A
    Cancer Res; 2000 Jun; 60(11):3019-24. PubMed ID: 10850451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
    Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
    Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG
    Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partially transformed T3T3 cells express high levels of mutant p53 in the 'wild-type' immunoreactive form with defective oligomerization.
    Milner J; Chan YS; Medcalf EA; Wang Y; Eckhart W
    Oncogene; 1993 Jul; 8(7):2001-8. PubMed ID: 8510941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour p53 mutations exhibit promoter selective dominance over wild type p53.
    Monti P; Campomenosi P; Ciribilli Y; Iannone R; Inga A; Abbondandolo A; Resnick MA; Fronza G
    Oncogene; 2002 Mar; 21(11):1641-8. PubMed ID: 11896595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.